Key result
This review evaluates the clinical data, ideal patient and lesion choice, and optimal implantation technique for the Magmaris resorbable magnesium scaffold.
Why the study?
To provide an up-to-date clinical evaluation of the Magmaris resorbable magnesium scaffold, the only currently available metallic bioresorbable scaffold, alongside key learning points on patient selection and implantation technique.
This review summarizes the current clinical data, patient selection, and optimal implantation techniques for the Magmaris resorbable magnesium scaffold.
Answers are grounded in this paper and cite their sources.
Magmaris merits selective evaluation in complex lesions; leaves open routine adoption pending randomized outcome data.
Bioresorbable scaffold (BRS) technology provides transient vessel support with drug-delivery capability without the long-term limitations of the permanent metallic drug-eluting stents (DES). Numerous scaffolds have been developed and investigated by device manufacturers, many of which, due to device deficiencies, have fallen by the wayside. This short review will focus on the resorbable magnesium scaffold Magmaris® the only metallic bioresorbable scaffold currently available, providing an evaluation of the most up to date clinical data whilst also briefly highlighting learning points regarding the ideal patient and lesion choice and optimal implantation technique.
No takes yet. Share an insight, caveat, or question.
Bennett et al. (2021) reported a review. Magmaris resorbable magnesium scaffold was evaluated. This review evaluates the clinical data, ideal patient and lesion choice, and optimal implantation technique for the Magmaris resorbable magnesium scaffold.
Synapse has enriched 10 related papers. Consider them for comparative context: